Insider Transactions Reported by 14 Insiders of PAVmed Inc.

Symbol
PAVM on Nasdaq
Location
New York, NY

Key facts

  • PAVM - PAVmed Inc. has 14 insiders with reported activity on this page.
  • No net insider buy/sell flow is currently reported for the last year.
  • Recent transaction rows are available for direct filing-level review.

Change

  • No meaningful buy/sell imbalance is currently visible in the one-year window.
  • Activity will update as new Forms 3/4/5 are filed.

Research use

  • This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
  • Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Evidence

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 24 May 2025.

Buys

$0

Shares: 0

Insiders: 0

Sells

$0

Shares: 0

Insiders: 0

Net

$0

Shares: 0

Insiders: 0

Window (months) Buy shares Sell shares Buy $ Sell $ Net $
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

PAVmed Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Tasso Partners, LLC 10%+ Owner $201,589 Mixed 27 Mar 2026
Aklog Lishan Chairman and CEO, Director $81,158 Mixed 02 Apr 2026
Dennis M. Mcgrath President and CFO $41,222 Mixed 02 Apr 2026
Joan B. Harvey Director $40,508 Mixed 22 Feb 2024
James L. Cox Director $40,508 Mixed 22 Feb 2024
Shaun O'Neil Chief Operating Officer $25,524 Mixed 02 Apr 2026
Michael A. Gordon General Counsel $25,392 Mixed 02 Apr 2026
Victoria Tou-Ho Lee Chief Medical Officer $15,823 Mixed 02 Apr 2026
Michael J. Glennon Director $4,780 Mixed 02 Apr 2026
Timothy E. Baxter Director $4,658 Mixed 02 Apr 2026
Ronald M. Sparks Director $4,658 Mixed 02 Apr 2026
Debra White Director $4,658 Mixed 02 Apr 2026
Sundeep Agrawal Director $4,269 Mixed 02 Apr 2026
Brian J. DeGuzman Chief Medical Officer Mixed 18 Feb 2022

Top shareholders of PAVmed Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Tasso Partners, LLC
13D/G 3/4/5
Dana Carrera · 10%+ Owner
15%
974,246
$215,114 -$353,303 27 Mar 2026
Two Seas Capital LP
13F 13D/G
Company
10%
from 13D/G
461,539
$4,684,621 31 Mar 2026
Ayrton Capital LLC
13D/G
10%
709,069
$170,177 -$124,139 31 Mar 2026
Scopia Holdings LLC
13D/G
Matthew Sirovich
9.9%
637,670
$140,798 $0 27 Mar 2026
FIRST MANHATTAN CO. LLC.
13F 13D/G
Company
9.6%
from 13D/G
23,805
$241,621 31 Mar 2026
David S. Nagelberg
13D/G
NAGELBERG DAVID S
8.6%
546,964
$120,770 $0 27 Mar 2026
Kallman Craig
13D/G
6%
384,616
$84,923 $0 27 Mar 2026
Sargent Investment Group, LLC
13D/G
5.8%
1,006,300
$604,183 $0 01 Jul 2025
Dols Scott V
13D/G
5.4%
346,155
$76,431 $0 27 Mar 2026
Aklog Lishan
13D/G 3/4/5
Chairman and CEO, Director
5.1%
369,068
$81,490 $0 02 Apr 2026
Dennis M. Mcgrath
3/4/5
President and CFO
2.8%
186,695
$41,222 02 Apr 2026
Shaun O'Neil
3/4/5
Chief Operating Officer
1.8%
115,598
$25,524 02 Apr 2026
Michael A. Gordon
3/4/5
General Counsel
1.7%
115,000
$25,392 02 Apr 2026
Victoria Tou-Ho Lee
3/4/5
Chief Medical Officer
1.1%
71,666
$15,823 02 Apr 2026
Michael J. Glennon
3/4/5
Director
0.33%
21,653
$4,780 02 Apr 2026
Debra White
3/4/5
Director
0.32%
21,097
$4,658 02 Apr 2026
Ronald M. Sparks
3/4/5
Director
0.32%
21,097
$4,658 02 Apr 2026
Timothy E. Baxter
3/4/5
Director
0.32%
21,097
$4,658 02 Apr 2026
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
11,777
$119,544 31 Mar 2026
13F
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
class O/S missing
5,917
$60,058 31 Mar 2026
13F
VANGUARD FIDUCIARY TRUST CO
13F
Company
class O/S missing
5,429
$55,104 31 Mar 2026
13F
James L. Cox
3/4/5
Director
class O/S missing
65,000
$40,508 22 Feb 2024
Joan B. Harvey
3/4/5
Director
class O/S missing
65,000
$40,508 22 Feb 2024
BlackRock, Inc.
13F
Company
class O/S missing
2,416
$24,522 31 Mar 2026
13F
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
622
$6,313 31 Mar 2026
13F
Sundeep Agrawal
3/4/5
Director
mixed-class rows
69,337
mixed-class rows
$4,269 02 Apr 2026
MORGAN STANLEY
13F
Company
class O/S missing
165
$1,675 31 Mar 2026
13F
CWM, LLC
13F
Company
class O/S missing
157
$1,594 31 Mar 2026
13F
UBS Group AG
13F
Company
class O/S missing
75
$760 31 Mar 2026
13F
SBI Securities Co., Ltd.
13F
Company
class O/S missing
67
$680 31 Mar 2026
13F
Vanguard Global Advisers, LLC
13F
Company
class O/S missing
61
$619 31 Mar 2026
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
45
$457 31 Mar 2026
13F
Allworth Financial LP
13F
Company
class O/S missing
6
$61 31 Mar 2026
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
4
$40 31 Mar 2026
13F
GROUP ONE TRADING LLC
13F
Company
class O/S missing
2
$20 31 Mar 2026
13F
AdvisorNet Financial, Inc
13F
Company
class O/S missing
1
$10 31 Mar 2026
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
class O/S missing
1
$10 31 Mar 2026
13F
Steward Partners Investment Advisory, LLC
13F
Company
class O/S missing
1
$10 31 Mar 2026
13F
JONES FINANCIAL COMPANIES LLLP
13F
Company
class O/S missing
1
$9 31 Mar 2026
13F
Brian J. DeGuzman
3/4/5
Chief Medical Officer
class O/S missing
50,000
18 Feb 2022

Recent Insider Transactions by Companies or Individuals for PAVmed Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Victoria Tou-Ho Lee PAVM Common Stock Award 4201.7% 70,000 71,666 02 Apr 2026 Direct
Lishan Aklog PAVM Common Stock Award 4596.8% 350,000 357,614 02 Apr 2026 Direct
Dennis M. Mcgrath PAVM Common stock Award 2688.6% 180,000 186,695 02 Apr 2026 Direct
Michael J. Glennon PAVM Common stock Award 180.4% 13,930 21,653 02 Apr 2026 Direct
Timothy E. Baxter PAVM Common stock Award 194.4% 13,930 21,097 02 Apr 2026 Direct
Debra White PAVM Common Stock Award 194.4% 13,930 21,097 02 Apr 2026 Direct
Ronald M. Sparks PAVM Common stock Award 194.4% 13,930 21,097 02 Apr 2026 Direct
Sundeep Agrawal PAVM Common Stock Award 257.6% 13,930 19,337 02 Apr 2026 Direct
Michael A. Gordon PAVM Common stock Award 2200% 110,000 115,000 02 Apr 2026 Direct
Shaun O'Neil PAVM Common Stock Award 1965% 110,000 115,598 02 Apr 2026 Direct
Ronald M. Sparks PAVM Common stock Award 230.8% 150,000 215,000 30 Sep 2025 Direct
Debra White PAVM Common stock Award 230.8% 150,000 215,000 30 Sep 2025 Direct
Timothy E. Baxter PAVM Common stock Award 230.8% 150,000 215,000 30 Sep 2025 Direct
Michael J. Glennon PAVM Common stock Award 183.7% 150,000 231,667 30 Sep 2025 Direct
Sundeep Agrawal PAVM Common Stock Award 1230% 150,000 162,195 30 Sep 2025 Direct
Michael A. Gordon PAVM Common Stock Award 150,000 150,000 30 Sep 2025 Direct
Dennis M. Mcgrath PAVM Common Stock Award 295.1% 150,000 200,834 30 Sep 2025 Direct
Lishan Aklog PAVM Common Stock Award 191.3% 150,000 228,418 30 Sep 2025 Direct
Shaun O'Neil PAVM Common Stock Award 836.4% 150,000 167,933 30 Sep 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .